β2-adrenoceptor polymorphisms and obstructive airway diseases: Important issues of study design

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 10, 2007, Pages 1029-1036

  Yang, Ian A ^a,b   Ng, Taria ^a   Molenaar, Peter ^a   Fong, Kwun M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

2 adrenoceptor genetics; Adrenergic; Asthma; Genetic; Polymorphism; Receptors

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; LONG ACTING DRUG; SHORT ACTING DRUG; BETA 2 ADRENERGIC RECEPTOR;

AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; PHARMACOGENOMICS; PHENOTYPE; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENETICS; METHODOLOGY; REVIEW; SAMPLE SIZE; TREATMENT OUTCOME;

AIRWAY OBSTRUCTION; ANIMALS; HUMANS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; RESEARCH DESIGN; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 34547993334     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04731.x     Document Type: Conference Paper

References (69)

1. NHLBI WHO. Global Initiative for Asthma (2005 update). National Institutes of Health Publication no. 95-3659. National Institutes of Health, Bethesda. 2005.
2. National Asthma Council. Asthma Management Handbook. National Asthma Council Australia Ltd, Melbourne. 2006.
3. O'Byrne PM, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet 2006 368 : 794 803.
4. Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006 368 : 780 93.
5. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur. Respir. J. 2004 23 : 932 46.
6. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLOS Med. 2006 3 : E442.
7. Croxton TL, Weinmann GG, Senior RM, Hoidal JR. Future research directions in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2002 165 : 838 44.
8. Abramson MJ, Crockett AJ, Frith PA, McDonald CF. COPDX. An update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. Med. J. Aust. 2006 184 : 342 5.
9. Ober C. Perspectives on the past decade of asthma genetics. J. Allergy Clin. Immunol. 2005 116 : 274 8.
10. Ober C, Hoffjan S. Asthma genetics 2006: The long and winding road to gene discovery. Genes Immun. 2006 7 : 95 100.
11. Weiss ST, Litonjua AA, Lange C et al. Overview of the pharmacogenetics of asthma treatment. Pharmacogenomics J. 2006 6 : 311 26.
12. Cookson WO. State of the art. Genetics and genomics of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2006 3 : 473 5.
13. Johnson M. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J. Allergy Clin. Immunol. 2006 117 : 18 24.
14. Giembycz MA, Newton R. Beyond the dogma: Novel beta2-adrenoceptor signalling in the airways. Eur. Respir. J. 2006 27 : 1286 306.
15. Broadley KJ. Beta-adrenoceptor responses of the airways: For better or worse? Eur. J. Pharmacol. 2006 533 : 15 27.
16. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006 129 : 15 26.
17. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 1993 8 : 334 9.
18. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994 33 : 9414 19.
19. Green SA, Turki J, Bejarano P, Hall IP, Liggett SB. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 1995 13 : 25 33.
20. Green SA, Cole G, Jacinto M, Innis M, Liggett SB. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 1993 268 : 23 116 21.
21. Green SA, Rathz DA, Schuster AJ, Liggett SB. The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s). Eur. J. Pharmacol. 2001 421 : 141 7.
22. McGraw DW, Forbes SL, Kramer LA, Liggett SB. Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J. Clin. Invest. 1998 102 : 1927 32.
23. Holloway JW, Yang IA. Beta2-adrenergic receptor polymorphism and asthma: True or false? J. Allergy Clin. Immunol. 2005 115 : 960 2.
24. Liggett SB. Genetic variability of the beta2 adrenergic receptor and asthma exacerbations. Thorax 2006 61 : 925 7.
25. Litonjua AA. The significance of beta2-adrenergic receptor polymorphisms in asthma. Curr. Opin. Pulm. Med. 2006 12 : 12 17.
26. Yang IA, Holgate ST, Holloway JW. Toll-like receptor polymorphisms and allergic disease: Interpreting the evidence from genetic studies. Clin. Exp. Allergy 2004 34 : 163 6.
27. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet 2005 366 : 1315 23.
28. Davey Smith G, Ebrahim S, Lewis S, Hansell AL, Palmer LJ, Burton PR. Genetic epidemiology and public health: Hope, hype, and future prospects. Lancet 2005 366 : 1484 98.
29. Hawkins GA, Tantisira K, Meyers DA et al. Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study. Am. J. Respir. Crit. Care Med. 2006 174 : 1101 9.
30. Matheson MC, Ellis JA, Raven J, Johns DP, Walters EH, Abramson MJ. Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults. J. Hum. Genet. 2006 51 : 943 51.
31. Wilson AM, Gray RD, Hall IP, Lipworth BJ. The effect of beta2-adrenoceptor haplotypes on bronchial hyper-responsiveness in patients with asthma. Allergy 2006 61 : 254 9.
32. Palmer CN, Lipworth BJ, Lee S, Ismail T, Macgregor DF, Mukhopadhyay S. Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax 2006 61 : 940 4.
33. Brøgger J, Steen VM, Eiken HG, Gulsvik A, Bakke P. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur. Respir. J. 2006 27 : 682 8.
34. Tsai HJ, Shaikh N, Kho JY et al. Beta 2-adrenergic receptor polymorphisms: Pharmacogenetic response to bronchodilator among African American asthmatics. Hum. Genet. 2006 119 : 547 57.
35. Fukui Y, Hizawa N, Takahashi D et al. Association between nonspecific airway hyperresponsiveness and Arg16Gly beta2-adrenergic receptor gene polymorphism in asymptomatic healthy Japanese subjects. Chest 2006 130 : 449 54.
36. Yin K, Zhang X, Qiu Y. Association between beta2-adrenergic receptor genetic polymorphisms and nocturnal asthmatic patients of Chinese Han nationality. Respiration 2006 73 : 464 7.
37. Munakata M, Harada Y, Ishida T et al. Molecular-based haplotype analysis of the beta 2-adrenergic receptor gene (ADRB2) in Japanese asthmatic and non-asthmatic subjects. Allergol. Int. 2006 55 : 191 8.
38. Snyder EM, Beck KC, Dietz NM, Joyner MJ, Turner ST, Johnson BD. Influence of beta2-adrenergic receptor genotype on airway function during exercise in healthy adults. Chest 2006 129 : 762 70.
39. Hall IP, Blakey JD, Al Balushi KA et al. Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: A genetic association study. Lancet 2006 368 : 771 9.
40. Lima JJ, Holbrook JT, Wang J et al. The C523A beta2 adrenergic receptor polymorphism associates with markers of asthma severity in African Americans. J. Asthma 2006 43 : 185 91.
41. Elbahlawan L, Binaei S, Christensen ML, Zhang Q, Quasney MW, Dahmer MK. Beta2-adrenergic receptor polymorphisms in African American children with status asthmaticus. Pediatr. Crit. Care Med. 2006 7 : 15 18.
42. Bleecker ER, Yancey SW, Baitinger LA et al. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. J. Allergy Clin. Immunol. 2006 118 : 809 16.
43. Wechsler ME, Lehman E, Lazarus SC et al. Beta-adrenergic receptor polymorphisms and response to salmeterol. Am. J. Respir. Crit. Care Med. 2006 173 : 519 26.
44. Telleria JJ, Blanco-Quiros A, Muntion S et al. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms. Respir. Med. 2006 100 : 1072 8.
45. van Veen A, Wierenga EA, Westland R et al. Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics. Respir. Res. 2006 7 : 19.
46. Moore PE, Cunningham G, Calder MM et al. Respiratory syncytial virus infection reduces beta2-adrenergic responses in human airway smooth muscle. Am. J. Respir. Cell Mol Biol. 2006 35 : 559 64.
47. Cardon LR, Bell JI. Association study designs for complex diseases. Nat. Rev. Genet. 2001 2 : 91 9.
48. Tabor HK, Risch NJ, Myers RM. Opinion. Candidate-gene approaches for studying complex genetic traits: Practical considerations. Nat. Rev. Genet. 2002 3 : 391 7.
49. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003 361 : 865 72.
50. Wjst M. Beta2-adrenoreceptor polymorphisms and asthma. Lancet 2006 368 : 710 11.
51. Israel E, Drazen JM, Liggett SB et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am. J. Respir. Crit. Care Med. 2000 162 : 75 80.
52. Israel E, Chinchilli VM, Ford JG et al. Use of regularly scheduled albuterol treatment in asthma: Genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004 364 : 1505 12.
53. Tattersfield AE, Harrison TW. Beta-adrenoceptor polymorphisms: Focus moves to long-acting beta-agonists. Am. J. Respir. Crit. Care Med. 2006 173 : 473 4.
54. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: Past successes for mendelian disease, future approaches for complex disease. Nat. Genet. 2003 33 (Suppl. 228 37.
55. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 2005 37 : 1217 23.
56. Healy DG. Case-control studies in the genomic era: A clinician's guide. Lancet Neurol. 2006 5 : 701 7.
57. Drysdale CM, McGraw DW, Stack CB et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl Acad. Sci. USA 2000 97 : 10 483 8.
58. Moore PE, Laporte JD, Abraham JH et al. Polymorphism of the beta (2)-adrenergic receptor gene and desensitization in human airway smooth muscle. Am. J. Respir. Crit. Care Med. 2000 162 : 2117 24.
59. Lipworth B, Koppelman GH, Wheatley AP et al. Beta2 adrenoceptor promoter polymorphisms: Extended haplotypes and functional effects in peripheral blood mononuclear cells. Thorax 2002 57 : 61 6.
60. Naline E, Zhang Y, Qian Y et al. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus. Eur. Respir. J. 1994 7 : 914 20.
61. Molimard M, Naline E, Zhang Y, Le Gros V, Begaud B, Advenier C. Long- and short-acting beta2 adrenoceptor agonists: Interactions in human contracted bronchi. Eur. Respir. J. 1998 11 : 583 8.
62. + channel blockers on beta-adrenergic- and NO-donor-mediated relaxations of human and guinea-pig airway smooth muscles. Naunyn Schmiedebergs Arch. Pharmacol. 1998 357 : 77 86.
63. Schmidt D, Kallstrom BL, Waldeck B, Branscheid D, Magnussen H, Rabe KF. The effect of the enantiomers of formoterol on inherent and induced tone in guinea-pig trachea and human bronchus. Naunyn Schmiedebergs Arch. Pharmacol. 2000 361 : 405 9.
64. Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz KN. Comparative pharmacology of human beta-adrenergic receptor subtypes: Characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch. Pharmacol. 2004 369 : 151 9.
65. Baker JG. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br. J. Pharmacol. 2005 144 : 317 22.
66. Molenaar P, Savarimuthu SM, Sarsero D et al. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta (2)-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling. Naunyn Schmiedebergs Arch. Pharmacol. 2007 375 : 11 28.
67. Todd JA. Statistical false positive or true disease pathway? Nat. Genet. 2006 38 : 731 3.
68. Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG, Ioannidis JP. Establishment of genetic associations for complex diseases is independent of early study findings. Eur. J. Hum. Genet. 2004 12 : 762 9.
69. Martinez FD. Genes, environments, development and asthma: A reappraisal. Eur. Respir. J. 2007 29 : 179 84.